Global  

Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk

Video Credit: Wochit News - Duration: 00:35s - Published
Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk

Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk

According to UPI, chloroquine and hydroxychloroquine has no clinical benefit for people with COVID-19.

A study published in The Lancet on Friday says that the drugs might actually cause serious heart-related side effects.

The study of 15,000 patients found increased rate of heart-related side effects, when taking either drug to treat COVID-19.

0
shares
ShareTweetSavePostSend
 

Related news from verified sources

Drug touted by Trump to treat COVID-19 linked to higher death risk: study

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking...
Reuters - Published Also reported by •Reuters IndiaSBSWorldNews


Coronavirus patients who took hydroxychloroquine had higher risk of death, study shows

An observational study of 15,000 COVID-19 patients treated with hydroxychloroquine or chloroquine...
USATODAY.com - Published


You Might Like


Tweets about this


Related videos from verified sources

World Health Organization Halts Trials Of Hydroxychloroquine [Video]

World Health Organization Halts Trials Of Hydroxychloroquine

The World Health Organization announced they are temporarily suspending clinical trials of hydroxychloroquine. The controversial drug has been used as an experimental coronavirus treatment for the..

Credit: Wochit     Duration: 00:38Published
Explained: Why WHO suspended hydroxychloroquine trials | Covid-19 [Video]

Explained: Why WHO suspended hydroxychloroquine trials | Covid-19

The World Health Organization has temporarily halted trials on hydroxychloroquine due to safety concerns. According to a study by The Lancet, patients given HCQ had higher death rates than those not on..

Credit: HT Digital Content     Duration: 05:09Published